Vaccine Coverage and Safety in Immunization Programs
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 674
Special Issue Editor
2. Shamir Medical Center (Assaf Harofeh), Zerifin 7033001, Israel
3. ICET—Israeli Center for Emerging Technologies, Zerifin 7033001, Israel
Interests: health care management; health education and promotion; hospital management; health technology assessment; emerging technologies and innovation; public health; insurance coverage; resorce allocation
Special Issue Information
Dear Colleagues,
Governments worldwide are responsible for providing better healthcare to their citizens, and increasing vaccination rates is a crucial part of this responsibility. The World Health Organization (WHO) considers vaccination rates an important comparative quality indicator. Structured immunization programs that are publicly funded demonstrate the resilience of the health system. Different vaccines are recommended for different populations, such as children (Polio, MMR), adults (Prevner, Zoster), or epidemic threats (influenza virus, COVID-19). Public adherence to vaccination reflects trust between the public and healthcare providers, and this trust can be enhanced when there is a good patient–doctor relationship.
The decision to accept vaccination is a personal choice that reflects the patient's autonomy, but this choice can be influenced by various factors, including the patient's willingness to vaccinate themselves or their children and their cultural beliefs. Concerns about possible side effects of the vaccine versus the severity of the disease can influence risk perceptions about vaccination. This dilemma can be even more complicated when there is uncertainty regarding the disease course and prognosis and the effectiveness of the vaccine.
Other barriers to vaccination include limited availability, reduced accessibility, lack of public funding, negative prior experience, influence of social groups discouraging vaccination or raising doubts regarding its effectiveness, disparities in information, or the absence of a credible source of information.
In addition to personal health responsibility and autonomy, vaccination adherence also expresses social values of solidarity by protecting others, especially vulnerable groups such as the elderly and immunocompromised patients. However, these values can sometimes conflict with clinical ethical dilemmas.
We cordially invite researchers to contribute their findings about vaccination challenges, including evidence of safety, estimated effectiveness, data analysis, and theoretical models. This Special Issue aims to focus on Vaccine Coverage and Safety in Immunization Programs, including clinical vaccine research, utilization, and immunization, as well as social and financial determinants that may influence access to immunization programs. We encourage scientists to publish their experimental results and theoretical insights, sharing their ideas and approaches for analyzing the relationships between vaccination safety and risk perception and between vaccination coverage and acceptance/hesitance.
We welcome relevant articles and reviews in the field of immunization/vaccination, including:
- Vaccination differences in specific population groups, gaps, and disparities, and vaccination trends;
- Immunization programs and their effect on vaccination rates;
- Risk perception, safety evaluations, and assessing vaccination effectiveness;
- Funding, costs, and regulations affecting vaccinations;
- Database analysis and BIG DATA, predictive models, cluster analysis;
- Relationship between vaccination and insurance coverage;
- Standpoints, concepts, and considerations for special populations, adherence gaps, hesitance, and refusals;
- Preference analysis, incentives, and barriers;
- Assessing benefits, safety, and effectiveness/cost-effectiveness of vaccines and vaccination programs;
- The roles of various stakeholders in determining vaccination programs.
I look forward to receiving your contributions.
Prof. Dr. Tal Orna
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccination
- safety
- coverage
- funding
- compliance
- barriers
- immunization programs
